Pages that link to "Q33799533"
Jump to navigation
Jump to search
The following pages link to Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder (Q33799533):
Displaying 15 items.
- Dopamine transporter gene variation modulates activation of striatum in youth with ADHD (Q30495097) (← links)
- Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders (Q33664787) (← links)
- Specific Genes Associated with Adverse Events of Methylphenidate Use in the Pediatric Population: A Systematic Literature Review (Q33777131) (← links)
- Dopamine transporter genotype and stimulant dose-response in youth with attention-deficit/hyperactivity disorder (Q33782844) (← links)
- Dopaminergic dysregulation in mice selectively bred for excessive exercise or obesity (Q34052751) (← links)
- A current update on ADHD pharmacogenomics (Q37710514) (← links)
- An 'integrative neuroscience' perspective on ADHD: linking cognition, emotion, brain and genetic measures with implications for clinical support (Q37798259) (← links)
- Drug policy and treatment bias due to the dopamine-deficit theory of child attention-deficit hyperactivity disorder (Q37856984) (← links)
- Attention-deficit/hyperactivity disorder genomics: update for clinicians (Q38030489) (← links)
- SLC6A3 polymorphism and response to methylphenidate in children with ADHD: A systematic review and meta-analysis. (Q48241287) (← links)
- Pharmacogenetics of methylphenidate response and tolerability in attention-deficit/hyperactivity disorder. (Q50266015) (← links)
- Neurotrophin 3 genotype and emotional adverse effects of osmotic-release oral system methylphenidate (OROS-MPH) in children with attention-deficit/hyperactivity disorder (Q50533661) (← links)
- Norepinephrine transporter -3081(A/T) and alpha-2A-adrenergic receptor MspI polymorphisms are associated with cardiovascular side effects of OROS-methylphenidate treatment. (Q50800347) (← links)
- The potential of pharmacogenomics to treat drug addiction. (Q52295623) (← links)
- Facing the Methodological Challenge in Dissecting the Genetics of ADHD: A Case for Deep Phenotyping and Heterogeneity Reduction (Q98288977) (← links)